PgR activation induces apoptosis, cell cycle arrest and senescence in ovarian cancer cells, which strongly suggests the modulation of PgR levels and/or activity as a form of endocrine treatment of EOC [77]. This evidence concerns the gene PGR and ovarian cancer.